BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27902363)

  • 1. Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study.
    Rahman S; Pierce Campbell CM; Waterboer T; Rollison DE; Ingles DJ; Torres BN; Michel A; Sudenga SL; Pawlita M; Villa LL; Lazcano Ponce E; Borenstein AR; Wang W; Giuliano AR
    J Gen Virol; 2016 Dec; 97(12):3291-3301. PubMed ID: 27902363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.
    Rahman S; Rollison DE; Pierce Campbell CM; Waterboer T; Michel A; Pawlita M; Villa LL; Lazcano Ponce E; Wang W; Borenstein AR; Giuliano AR
    PLoS One; 2016; 11(11):e0167174. PubMed ID: 27893841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.
    Rahman S; Pierce Campbell CM; Rollison DE; Wang W; Waterboer T; Michel A; Pawlita M; Villa LL; Lazcano Ponce E; Borenstein AR; Giuliano AR
    PLoS One; 2016; 11(11):e0167173. PubMed ID: 27902759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous HPV and alpha-mucosal 9-valent HPV sero-status associations.
    Rahman S; Giuliano AR; Rollison DE; Pawlita M; Waterboer T; Villa LL; Lazcano Ponce E
    Papillomavirus Res; 2017 Dec; 4():54-57. PubMed ID: 29179870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study).
    Lu B; Viscidi RP; Lee JH; Wu Y; Villa LL; Lazcano-Ponce E; da Silva RJ; Baggio ML; Quiterio M; Salmerón J; Smith DC; Abrahamsen M; Papenfuss M; Stockwell HG; Giuliano AR
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):990-1002. PubMed ID: 21378268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
    Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
    J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
    Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
    Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin.
    Iannacone MR; Gheit T; Waterboer T; Giuliano AR; Messina JL; Fenske NA; Cherpelis BS; Sondak VK; Roetzheim RG; Michael KM; Tommasino M; Pawlita M; Rollison DE
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1303-13. PubMed ID: 22707711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
    Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
    Kreimer AR; Alberg AJ; Viscidi R; Gillison ML
    Sex Transm Dis; 2004 Apr; 31(4):247-56. PubMed ID: 15028941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.
    Wilson LE; Pawlita M; Castle PE; Waterboer T; Sahasrabuddhe V; Gravitt PE; Schiffman M; Wentzensen N
    Int J Cancer; 2013 Nov; 133(9):2172-81. PubMed ID: 23588935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of human papillomavirus in the anal canal of men: the HIM Study.
    Sichero L; Nyitray AG; Nunes EM; Nepal B; Ferreira S; Sobrinho JS; Baggio ML; Galan L; Silva RC; Lazcano-Ponce E; Giuliano AR; Villa LL;
    Clin Microbiol Infect; 2015 May; 21(5):502-9. PubMed ID: 25698660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients.
    Sampogna F; Bavinck JNB; Pawlita M; Abeni D; Harwood CA; Proby CM; Feltkamp MCW; Euvrard S; Naldi L; Neale RE; Nindl I; Pfister H; Quint WGV; Waterboer T; The Epi-Hpv-Uv-Ca Group
    J Gen Virol; 2012 Jan; 93(Pt 1):165-174. PubMed ID: 21900419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: antibodies to cutaneous human papillomaviruses.
    Antonsson A
    J Med Virol; 2012 May; 84(5):814-22. PubMed ID: 22431031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.
    Scherpenisse M; Mollers M; Schepp RM; Boot HJ; Meijer CJ; Berbers GA; van der Klis FR; de Melker HE
    PLoS One; 2012; 7(11):e48807. PubMed ID: 23152809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study.
    Sichero L; Pierce Campbell CM; Fulp W; Ferreira S; Sobrinho JS; Baggio M; Galan L; Silva RC; Lazcano-Ponce E; Giuliano AR; Villa LL;
    BMC Infect Dis; 2014 Dec; 14():677. PubMed ID: 25857319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries.
    Rahman S; Wathington D; Waterboer T; Pawlita M; Villa LL; Lazcano-Ponce E; Willhauck-Fleckenstein M; Brenner N; Giuliano AR
    PLoS One; 2021; 16(6):e0253005. PubMed ID: 34157055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.
    Loenenbach AD; Poethko-Müller C; Pawlita M; Thamm M; Harder T; Waterboer T; Schröter J; Deleré Y; Wichmann O; Wiese-Posselt M
    Int J Infect Dis; 2019 Jun; 83():3-11. PubMed ID: 30904676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses following incident anal and penile infection with human papillomavirus in teenage men who have sex with men.
    Zou H; Tabrizi SN; Grulich AE; Hocking JS; Garland SM; Bradshaw CS; Cornall AM; Fairley CK; Chen MY
    Int J Cancer; 2016 Aug; 139(3):639-46. PubMed ID: 26991809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
    Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
    Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.